Chenglin Han

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 5

Top Topics

Reactive Oxygen Species

Top Venues

Oxidative medicine and cellular longevity

Journal of oncology

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Chenglin Han, Zilong Wang, Shuxiao Chen, Lin Li, Yingkun Xu, Weiting Kang, Chunxiao Wei, Hongbin Ma, Muwen Wang, Xunbo Jin
Erratum to "Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF- κ B Axis". Oxidative medicine and cellular longevity 2021 (2021)
Chenglin Han, Zilong Wang, Shuxiao Chen, Lin Li, Yingkun Xu, Weiting Kang, Chunxiao Wei, Hongbin Ma, Muwen Wang, Xunbo Jin
Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis. Oxidative medicine and cellular longevity 2021 (2021)
Shuxiao Chen, Chenglin Han, Shuai Bian, Jianfeng Chen, Xuedong Feng, Gang Li, Xuejun Wu
Chemerin-9 Attenuates Experimental Abdominal Aortic Aneurysm Formation in ApoE-/- Mice. Journal of oncology 2021 (2021)
Chenglin Han, Zilong Wang, Yingkun Xu, Shuxiao Chen, Yuqing Han, Lin Li, Muwen Wang, Xunbo Jin
Roles of Reactive Oxygen Species in Biological Behaviors of Prostate Cancer. BioMed research international 2020 (2020)
Guangzhen Wu, Yingkun Xu, Chenglin Han, Zilong Wang, Jiayi Li, Qifei Wang, Xiangyu Che
Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway Exploration. Journal of oncology 2020 (2020)